Antiviral drugs are in great need to target newly evolving viral threats. We showed that an entry inhibitor with a very high binding affinity can effectively block the binding of the virus to its receptors on human cells. Those receptors are sialic acids. The work has been published in the scientific journal: Journal of the American Chemical Society. This project serves only as an example.